1 / 39

Changing culture: Perspectives on transforming clinical microbiological practice

Changing culture: Perspectives on transforming clinical microbiological practice. Dr Valerie Bevan Head of Department for Evaluations, Standards and Training valerie.bevan@hpa.org.uk www.evaluations-standards.org.uk. Celebrating 25 years of the BSMT 14 May 2010. Influencing factors

ervin
Télécharger la présentation

Changing culture: Perspectives on transforming clinical microbiological practice

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Changing culture: Perspectives on transforming clinical microbiological practice Dr Valerie Bevan Head of Department for Evaluations, Standards and Training valerie.bevan@hpa.org.uk www.evaluations-standards.org.uk Celebrating 25 years of the BSMT 14 May 2010

  2. Influencing factors Health and safety Quality Methods Technology Other influences Political Financial Education & training Science Professional Customer Cultural Equality and diversity (race, disability, gender, age, sexual orientation, religion and belief) Structure of talk

  3. Health and safety • 1957 lab workers 2-9 times more likely to die of TB than others • 1969-70 Edinburgh - hepatitis outbreak (8 pts; 3 staff died) • 1973 London School of Hygiene - Smallpox escape • Perceptions of risk

  4. Health and Safety • Health and Safety at Work etc Act 1974 • Howie Report 1978, 1983 (JW Howie and CH Collins) • Report of the Working Party to Formulate a Code of Practice for the Prevention of Infection in Clinical Laboratories (the "Howie Report") • The Howie Code (1978) • Code of Practice for the Prevention of Infection in Clinical Laboratories and Post-mortem Rooms (the “Howie Code")

  5. Howie Report • Although an early draft had been "leaked“ and was published in a trades union journal the Report has not been published by the Department. • The reasons for this were never made clear to members of the Working Party which produced it, nor to the newspapers which supported publication. • It may be relevant here to note that only one of the five recommendations made in the Report (testing of equipment by the PHLS) has been implemented. • For details see Howie and Collins ‘The Code of Practice’

  6. H&S Legislation • Health and Safety (Dangerous Pathogens) Regulations 1981 • Control of Substances Hazardous to Health Regulations 1988 (COSHH) (EC Directive 80/1107/EEC) • Amended 1996, 1887, 1998, 2001 • Replaced by 2002 COSHH Regulations (EC Directive 98/24/EC) (amended 2003, 2004)

  7. H&S • Advisory Committee on Dangerous Pathogens (ACDP) "Categorisation of biological agents according to hazard and categories of containment" 4th ed, 1995 • ACDP "The management, design and operation of microbiological containment laboratories" published 2001 • Health Services Advisory Committee (HSAC) guidance, "Safe working and the prevention of infection in clinical laboratories and similar facilities" (updated in 2003) • ACDP 2005 "Biological agents: managing the risks in laboratories and healthcare premises"

  8. Is it true that more Americans who were in the Twin Towers have died in car crashes since 9/11/2001 than died in the 9/11 atrocity? • Car crashes kill 400 times more people than international terrorism does in developed countries

  9. History of Quality • Guilds system (12th-19th Century - master craftsmen, journeymen) • Industrial revolution (18th-19th Century, mass production) • Rise of technology (tools, machines, factories, iron prod) • Mass production (Ford cars) • 1st World War (munitions) • Need for inspection • Technical Inspection Association (1919) • Walter Shewart (QC stats 1920s)

  10. History of Quality • Post WW2 quality (Japan, Toyota) • 1980s (quality revolution in US) • 1990s (service industries, JIT, TQM, Six Sigma, ZDP, Benchmarking, LEAN etc) • 1970 external quality assessment (40th anniversaries) • Late 1980s (CPA-UK) lab accreditation • ISO 9001:2000 – Quality Management System • ISO 13485:2003 – QMS for Medical Devices

  11. Quality • IVD Directive 98/79/EC on in vitro Diagnostic Medical Devices • 2002 UK - Medical Devices Regulations – consumer protection • 2008-9 (CPA-UKAS) • ISO 15189:2003 – International standards for medical laboratories • EC Medical Devices Directives – Guidance Notes on in vitro Diagnostic medical devices 98/79/EC (The CE Marking) • NICE • EBM

  12. What do we mean by “Quality”? • “The degree to which a set of inherent characteristics fulfils requirements” • ISO 9000

  13. What do we mean by “Quality”? • What do you look for in a car? • Point A to point B? • Speed? • Colour? • Manual vs Automatic? • Diesel vs Petrol? • Good stereo? • Practicality vs styling?

  14. What do we mean by ‘Quality’? A subjective term for which each person has his or her own definition • In technical usage, quality can have two meanings: • the characteristics of a product or service that bear on its ability to satisfy stated or implied needs • a product or service free of deficiencies • Source: American Society for Quality http://www.asq.org/glossary/q.html

  15. Quality in the laboratory • The right result on the right specimen from the right patient that is accurate, timely, and properly interpreted

  16. Vironostika Ag/Ab Vitros ECi anti-HIV 1+2 Genscreen PLUS HIV AgAb Genscreen HIV Version 2 Detect-HIV v.4 Access HIV 1/2 New Vidas DUO Enzygnost HIV Integral Genscreen ULTRA HIV Ag-Ab Ortho Ab Capt. ELISA AxSYM HIV Ag/Ab Combo Vironostika Ag/Ab update Clonesystems Detect HIV v1 Architect HIV Ag/Ab combo Vironostika HIV Uni-Form II plus O Roche combi HIV Murex HIV 1.2.0 Enzygnost HIV1/2 plus 0 5 10 15 20 25 Earliest anti-HIV Detection Earliest HIV Detection AxSYM HIV 1/2 gO Innotest HIV1/2 Murex HIV AgAb Combination IMx HIV1/2 III plus Biotest Anti-HIV Tetra ELISA Biotest HIV 1/2 recombinant Prism HIV Ag/Ab Combo = Combined Ag/Ab assay; = antiglobulin assay. = immunometric assay; = Class specific antibody capture assay;

  17. Test selection Patient preparation Specimen Selection Specimen collection Specimen preservation Specimen reception Results dispatched Unique lab identifier Laboratory Results interpreted Analysis SOPs EQA IQA QA IQC Analytical validation Clinical management Clinical validation Reporting and Interpretation Patient Quality Assurance [Seth J. Quality Assurance. In: CP Price, DJ Newham (eds) Principles and Practice of Immunoassay. 2nd ed. London. pp 211-228]

  18. What do we mean by Quality Management? Quality Management System (QMS) • Quality manual • Meeting accreditation standards • Adequate quality assurance (EQA, IQC, IQA) • Validated methods, equipment & kits • Having good SOPs

  19. What do we mean by assuring quality? • Having a ‘service culture’ focussed on the user / clinician and patient • Timely, high quality clinical advice and interpretation of results • Good reporting of all diseases for surveillance • Public health focus

  20. Quality Accounts DH expectations • Quality Accounts should assume the same significance for NHS as financial accounts • For the first time, all organisations will account publicly for the quality of care they provide • The first Quality Accounts will (subject to legislation) be published in 2010, based on information about quality improvement in 2009/10 • Measures therefore need to be identified and in place prior to April 2009

  21. Test selection Patient preparation Specimen Selection Specimen collection Specimen preservation Specimen reception Results dispatched Unique lab identifier Laboratory Results interpreted Analysis SOPs EQA IQA QA IQC Analytical validation Clinical management Clinical validation Reporting and Interpretation Patient Quality Assurance [Seth J. Quality Assurance. In: CP Price, DJ Newham (eds) Principles and Practice of Immunoassay. 2nd ed. London. pp 211-228]

  22. Background 2002 Need for standardised methods • Need for • co-ordinated system for evaluation • managed intro of new technology

  23. INVESTIGATION OF FAECES SPECIMENS FOR BACTERIAL PATHOGENS BSOP 30

  24. Clinical Guidance Notes (QSOP)

  25. Background ~Over 200 National Standard Methods • 84 Clinical bacteriology • BSOPs 37 • BSOPIDs/BSOPTPs 47 • 41 Virology / serology algorithms and SOPs • 40 Food, water and environmental • 39 Guidance Notes • 2 Syndromic algorithms (+3 in development)

  26. National Working Groups National Standard Method Working Groups • All day meetings every 2 monthsWorking Groups • Virology • Bacteriology • Syndromic Algorithms • Molecular Technology (being formed) • Food, Water and Dairy • Group membership • Chair • Head of Standards Unit • Two staff write, co-ordinate process • Medical, clinical and biomedical scientists • Stakeholders (AMM, CVN, ACM, IBMS, SGM, UK wide, Wales, Scotland, N Ireland other networks)

  27. Documents are based on: Experimental evidence Scientific literature

  28. Access www.hpa-standardmethods.org.uk www.evaluations-standards.org.uk www.hpa.org.uk • Final versions in Adobe .pdf format • Access to drafts and reviews (in MS Word) requires password • Over 1500 passwords in 75 countries to access our website for NSMs

  29. Syndromic algorithms • Bench level guide • ‘Front end’ • Link bacteriology and virology testing • Make informed decisions • Selection of tests • Appropriate samples • Appropriate reporting • Cross referencing to relevant NSMs

  30. Syndromic algorithms Hepatitis in Neonates

  31. Molecular Virology • Accelerating progress to molecular methodologies • Quantitative PCR • HIV, HCV, HBV, CMV, EBV • SARS, influenza A H5N1, influenza A & B • Replacement of previous methodology • Chlamydia EIA - withdrawal of VSOP 1 • Technology change – withdrawal of VSOP 19 • Tissue culture • conversion to PCR - • respiratory viruses, herpesviruses, enteroviruses

  32. Why use NSMs? • Consensus / wide literature review • Help you with accreditation • Wide consultation • Professionally led / hosted by HPA • Supported by NHS, professional and management organisations / experts / Links with MHRA, VLA, CVN, all microbiology, public health / epidemiologists • Honest broker • Involvement of key people eg eminent Medical Editors, experts on Bacteriology, Virology, Food/Water, TB, Parasites, Mycology • Free! (ASM Cumitech online $249.95 / annual renewal $99.95)

  33. How can you become a password holder • Two main routes: • Fill in the form at the front of the room • E-mail standards@hpa.org.uk • Get involved in the process become a password holder!

  34. Acknowledgements • Thanks to all staff in Department for Evaluations Standards and Training • Ruhi Siddiqui, Head of Standards Unit • Ian Sharp, Head of Quality Systems Unit • Satnam Sagoo, Head of Education and Training Unit • Keith Perry, seconded to Department of Health • Joe Vincini, National Reference Laboratory, Melbourne • Dr Ken Mutton, Chair of the Virology Working Group • Jon White, Head of Medical Illustration • and • Dr Rob George (sorry about the photo) • David Naylor for history of quality • www.hpa.org.uk • www.evaluations-standards.org.uk • www.bsmt.org.uk

More Related